Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
20.9M
-
Number of holders
-
56
-
Total shares
-
65.5M
-
Shares change
-
+2.93M
-
Total reported value, excl. options
-
$104M
-
Value change
-
+$5.75M
-
Number of buys
-
20
-
Number of sells
-
-27
-
Price
-
$1.59
Significant Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q2 2023
56 filings reported holding ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share as of Q2 2023.
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.5M shares
.
Largest 10 shareholders include COMMODORE CAPITAL LP (10M shares), FMR LLC (7.76M shares), MORGAN STANLEY (6.97M shares), BANK OF AMERICA CORP /DE/ (5.59M shares), BML Capital Management, LLC (5.16M shares), Versant Venture Management, LLC (5.07M shares), GOLDMAN SACHS GROUP INC (4.56M shares), VANGUARD GROUP INC (4.06M shares), VR Adviser, LLC (3.89M shares), and Sonic GP LLC (2M shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.